Rebecca Marnocha
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Cancer Research top 10%
- Co-authors
- George WildingDona AlbertiKendra D. TutschRhoda ArzoomanianJens C. EickhoffJill KolesarJames P. ThomasHoward H. Bailey
- Topics
- Cancer Treatment and Pharmacology (12 papers)Cancer therapeutics and mechanisms (7 papers)Peptidase Inhibition and Analysis (6 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- United StatesSpainCanada
In The Last Decade
Rebecca Marnocha
35 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 726
- Oncology 476
- Pulmonary and Respiratory Medicine 260
- Immunology 208
- Cancer Research 203
Countries citing papers authored by Rebecca Marnocha
This map shows the geographic impact of Rebecca Marnocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Marnocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Marnocha more than expected).
Fields of papers citing papers by Rebecca Marnocha
This network shows the impact of papers produced by Rebecca Marnocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Marnocha. The network helps show where Rebecca Marnocha may publish in the future.
Co-authorship network of co-authors of Rebecca Marnocha
This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Marnocha. A scholar is included among the top collaborators of Rebecca Marnocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Marnocha. Rebecca Marnocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 45 | |
| 3 | 24 | |
| 4 | 39 | |
| 5 | 17 | |
| 6 | 6 | |
| 7 | 16 | |
| 8 | 30 | |
| 9 | 13 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | 2 | |
| 13 | 25 | |
| 14 | 21 | |
| 15 | 3 | |
| 16 | 100 | |
| 17 | Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy. | 2 |
| 18 | Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer. | 57 |
| 19 | 16 | |
| 20 | 11 |
About Rebecca Marnocha
Rebecca Marnocha is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Cancer therapeutics and mechanisms (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Oncology (476 citations), Immunology and Allergy (84 citations) and Cancer Research (203 citations). Rebecca Marnocha has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include George Wilding, Dona Alberti, Kendra D. Tutsch, Rhoda Arzoomanian, Jens C. Eickhoff, Jill Kolesar, James P. Thomas, Howard H. Bailey, Glenn Liu and Douglas G. McNeel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.